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Agent
A number of names have been used for the coccidian flagellate 
protozoan parasite Giardia – G duodenalis, G lamblia and G intestinalis.
Giardia can infect a number of hosts including man. Seven different
molecular subtypes have been identified, designated A to G. F is the
subgroup seen in cats, whereas A and B are the main subgroups in
man.1 This is, therefore, not considered to be a zoonotic infection.2,3
Life cycle
The parasite has a direct life cycle. It lives in the lower small intestine
of the cat in its trophozoite form, adherent to the intestinal wall. It
replicates by binary fission to produce the encysted form, which is
passed in the faeces in addition to the trophozoites.
Epidemiology
Giardia is transmitted by the faecal–oral route. Although trophozoites
are excreted in the faeces, these do not survive well in the environment
and are unlikely to cause infection. In contrast, cysts are highly infec-
tious and successful transmission requires only a small number to be
ingested. The cysts can survive in the environment for up to several
months in ideal conditions and indirect transmission via faecal 
contamination can occur.
Epidemiological studies in different countries, and sampling of 
different cat populations, have shown a variable prevalence. While
dependent on the diagnostic screening test used, generally a preva-
lence of 1–20% has been reported.4–6 In some studies the prevalence in
cats with diarrhoea has not been notably different as compared with
healthy cats.
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Overview: Giardia is a protozoan parasite that
infects the small intestine of cats and can cause
diarrhoea. The biotypes that affect cats do not
appear to infect humans. Infection is most
common in young cats, particularly from 
multicat backgrounds. 
Disease signs: Infected cats that develop
clinical signs show small intestinal diarrhoea 
and there may be associated weight loss. 
Diagnosis: Diagnosis of infection is usually
based on an in-practice ELISA for faecal antigen
or zinc sulphate flotation of several pooled faecal
samples. Polymerase chain reaction (PCR) tests
are available but not used so widely. Infection
can be detected in clinically healthy cats so
interpretation of a positive result in cats with
diarrhoea requires care. 
Treatment: Fenbendazole or metronidazole are
regarded as the treatments of choice. Secondary
gut changes may be slow to resolve and so
diarrhoea may continue for some time after
infection has been eliminated.
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Pathogenesis
The parasite can cause damage
to and loss of the epithelial cells
of the lower small intestine, 
provoking an inflammatory
response. There may be blunt-
ing of the intestinal villi, lead-
ing to malabsorption.
Clinical signs
Young cats are more susceptible to both infec-
tion and associated disease, with most clinical
infections occurring in cats under 1 year of
age. Many infections are not followed by 
overt disease, and the importance of Giardia
as a diarrhoeal pathogen in cats is not 
clear. Experimental infections have induced
clinical signs, but not in all cases. The 
mechanism by which diarrhoea is induced is
also not clear, but thought to be related to 
malabsorption; there may be accompanying
weight loss, which is a prominent feature in
some cases. The diarrhoea is typically of a
small intestinal nature, with passage of liquid
or semi-liquid faeces, but may sometimes
show large intestinal features, with the inclu-
sion of mucus/blood. The clinical course may
last for weeks.
Immunity
The immune response to Giardia infection is
poorly understood in cats. Based on informa-
tion from infection in other species, it is pre-
sumed that cellular immunity and an IgA
response are key to providing protective
immunity.
Diagnosis
The infection is diagnosed using direct exam-
ination of faecal smears (wet mount examina-
tion), faecal flotation methods, faecal ELISA
antigen assays, direct immunofluorescence on
faecal smears and PCR. 
Trophozoites can be identified in fresh 
faecal smears. They are motile with a rolling
action. A small amount of freshly passed 
faeces or mucus is mixed with a drop of 
saline solution on a microscope slide, covered
with a coverslip and immediately examined
under a microscope at a magnification of x100.
Further examination at x400 allows definitive
identification. It is also possible to examine 
for trophozoites using microscopy of duode-
nal aspirates collected during endoscopic
small intestinal intubation. Giardia resides 
further down the small intestine of cats,
beyond the reach of upper endoscopic 
intubation.7
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A zinc sulphate flotation
method is recommended for 
faecal screening. Excretion of
cysts is erratic and therefore sev-
eral (usually three) faecal samples
collected on consecutive or alter-
native days should be screened.
Routine saturated salt or sucrose
methods are unsatisfactory since
they lead to distortion of the cysts.
It is also possible to use a direct
fluorescent antibody technique to
detect cysts in faecal smears, a test not widely
used in Europe. 
ELISA techniques for detecting antigen in fae-
ces are available, including an in-practice SNAP
test (IDEXX Ltd), but do not appear to be more
sensitive than careful faecal screening [EBM
grade IV].8 Recent studies have shown that
ELISA detection of antigen correlates well with
direct fluorescent antibody screening results.9
PCR tests are available but not widely used.
They have the advantage of being able to
identify the subtype present. However, PCR-
based studies have shown a high proportion
of positives (up to 80%), which has raised 
concerns that they may detect infections that
are not clinically relevant.10
The faecal flotation method has been the
standard test used in the past, but the in-
practice faecal antigen test appears to be
equally sensitive and specific, and is conven-
ient to perform [EBM grade I]. Examination of
faecal smears is cheap and has the advantage
of identifying other potential parasites – but it
is not popular in practice and less sensitive.11
A pragmatic approach often used by practi-
tioners as an alternative to testing is to assess
the response to treatment.
Treatment
The standard treatment of Giardia infection
has generally been an imidazole, usually fen-
bendazole, given at 50 mg/kg for 5–7 days
[EBM grade II].12,13 However, metronidazole is
an alternative, and the original recommenda-
tion was to use it at a dosage of 50 mg/kg for
5 days. This dosage carries an increased risk of
side effects – central nervous system toxicity
causing weakness, ataxia, disorientation and
seizures. Recently, it has been suggested that a
daily dosage of 25 mg/kg is effective, which is
unlikely to induce side effects [EBM grade IV].
Prevention
A vaccine based on inactivated trophozoites
(Giardia Vax; Fort Dodge/Pfizer) has been
used in the USA, but not in Europe, and is no
longer available. It was used for treatment as
well as for prevention.
European Advisory Board on Cat Diseases
The European Advisory Board on Cat Diseases (ABCD)
is a body of experts in immunology, vaccinology and
clinical feline medicine that issues guidelines on
prevention and management of feline infectious diseases
in Europe, for the benefit of the health and welfare of cats.
The guidelines are based on current scientific knowledge
of the diseases and available vaccines concerned.
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